BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 16900783)

  • 21. Upregulation of endoglin (CD105) expression during childhood brain tumor-related angiogenesis. Anti-angiogenic therapy.
    Bodey B; Bodey B; Siegel SE; Kaiser HE
    Anticancer Res; 1998; 18(3A):1485-500. PubMed ID: 9673360
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Geminin: a good prognostic factor in high-grade astrocytic brain tumors.
    Shrestha P; Saito T; Hama S; Arifin MT; Kajiwara Y; Yamasaki F; Hidaka T; Sugiyama K; Kurisu K
    Cancer; 2007 Mar; 109(5):949-56. PubMed ID: 17262828
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cyclooxygenase-2 (cox-2) expression and angiogenesis in intracranial ependymomas.
    Onguru O; Kurt B; Gunhan O; Soylemezoglu F
    Clin Neuropathol; 2006; 25(5):216-20. PubMed ID: 17007443
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Caveolin-1 expression is variably displayed in astroglial-derived tumors and absent in oligodendrogliomas: concrete premises for a new reliable diagnostic marker in gliomas.
    Cassoni P; Senetta R; Castellano I; Ortolan E; Bosco M; Magnani I; Ducati A
    Am J Surg Pathol; 2007 May; 31(5):760-9. PubMed ID: 17460461
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunocytochemical detection of leukocyte-associated and apoptosis-related antigen expression in childhood brain tumors.
    Bodey B; Bodey B; Siegel SE; Kaiser HE
    Crit Rev Oncol Hematol; 2001; 39(1-2):3-16. PubMed ID: 11418297
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular pathogenesis of pediatric astrocytic tumors.
    Nakamura M; Shimada K; Ishida E; Higuchi T; Nakase H; Sakaki T; Konishi N
    Neuro Oncol; 2007 Apr; 9(2):113-23. PubMed ID: 17327574
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Galectin-3: a useful biomarker for differential diagnosis of brain tumors.
    Park SH; Min HS; Kim B; Myung J; Paek SH
    Neuropathology; 2008 Oct; 28(5):497-506. PubMed ID: 18384511
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cyclooxygenase-2 (Cox-2) expression and angiogenesis in glioblastoma.
    Onguru O; Gamsizkan M; Ulutin C; Gunhan O
    Neuropathology; 2008 Feb; 28(1):29-34. PubMed ID: 18181832
    [TBL] [Abstract][Full Text] [Related]  

  • 29. EGFR activation results in enhanced cyclooxygenase-2 expression through p38 mitogen-activated protein kinase-dependent activation of the Sp1/Sp3 transcription factors in human gliomas.
    Xu K; Shu HK
    Cancer Res; 2007 Jul; 67(13):6121-9. PubMed ID: 17616668
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of cell cycle inhibitors p21, p27, p14 and p16 in gliomas. Correlation with classic prognostic factors and patients' outcome.
    Zolota V; Tsamandas AC; Aroukatos P; Panagiotopoulos V; Maraziotis T; Poulos C; Scopa CD
    Neuropathology; 2008 Feb; 28(1):35-42. PubMed ID: 18181833
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pitfalls in the assessment of MGMT expression and in its correlation with survival in diffuse astrocytomas: proposal of a feasible immunohistochemical approach.
    Capper D; Mittelbronn M; Meyermann R; Schittenhelm J
    Acta Neuropathol; 2008 Feb; 115(2):249-59. PubMed ID: 17965865
    [TBL] [Abstract][Full Text] [Related]  

  • 32. COX-2 and c-kit expression in canine gliomas.
    Jankovsky JM; Newkirk KM; Ilha MR; Newman SJ
    Vet Comp Oncol; 2013 Mar; 11(1):63-9. PubMed ID: 22235799
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Histological and molecular classification of gliomas].
    Figarella-Branger D; Colin C; Coulibaly B; Quilichini B; Maues De Paula A; Fernandez C; Bouvier C
    Rev Neurol (Paris); 2008; 164(6-7):505-15. PubMed ID: 18565348
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Nitric oxide synthase in neuroepithelial brain tumors].
    Sosunov AA; Chairkin IN; Odyvanova LR; Guski G; Tservos-Navarro DZh
    Arkh Patol; 1997; 59(6):61-5. PubMed ID: 9483223
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Expression of cyclooxygenase (COX)-2 in astrocytic tumors and anti-tumor effects of selective COX-2 inhibitors].
    Murakami H; Sawa H; Kamada H
    No To Shinkei; 2006 Jan; 58(1):43-9. PubMed ID: 16482921
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of the IDH1 codon 132 mutation in brain tumors.
    Balss J; Meyer J; Mueller W; Korshunov A; Hartmann C; von Deimling A
    Acta Neuropathol; 2008 Dec; 116(6):597-602. PubMed ID: 18985363
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Expression of myelin basic protein and glial fibrillary acidic protein genes in human glial brain tumors].
    Dmytrenko VV; Boĭko OI; Shostak KO; Bilets'kyĭ AV; Malysheva TA; Shamaiev MI; Kliuchka VM; Rozumenko VD; Zozulia IuP; Kavsan VM
    Tsitol Genet; 2009; 43(1):28-35. PubMed ID: 19663312
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantitative apparent diffusion coefficients in the characterization of brain tumors and associated peritumoral edema.
    Server A; Kulle B; Maehlen J; Josefsen R; Schellhorn T; Kumar T; Langberg CW; Nakstad PH
    Acta Radiol; 2009 Jul; 50(6):682-9. PubMed ID: 19449234
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of matrix metalloproteinases MMP-1, MMP-11 and MMP-19 is correlated with the WHO-grading of human malignant gliomas.
    Stojic J; Hagemann C; Haas S; Herbold C; Kühnel S; Gerngras S; Roggendorf W; Roosen K; Vince GH
    Neurosci Res; 2008 Jan; 60(1):40-9. PubMed ID: 17980449
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Monoclonal antibody to stage-specific fetal brain 68-kDa glycoprotein (FGP68) revealed increased FGP68 expression in human primary brain tumors.
    Kato S; Shinozawa T; Nagashige H; Nakamura M; Asano Y; Takikawa M; Kato M; Awaya A; Hirano A; Ohama E
    Acta Neuropathol; 2002 Jul; 104(1):57-66. PubMed ID: 12070665
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.